Optimisation of once-a-day oral sustained-release formulations for the novel antihypertensive drug MT-1207
Background: Hypertension is a common chronic disease that increases the risk of cardiovascular disease. Sustained-release formulations are designed to maintain therapeutic levels of drugs throughout the course of hypertension treatment, thereby increasing patient compliance and enhancing patient out...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2022
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/67502/ |